Prevnar 20 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5W3G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,467
Award facts
- Contract value 100% obligated
- $33,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 29, 2026, the Defense Logistics Agency awarded a delivery order valued at $33,467 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This firm fixed-price contract, which is not set aside for any specific business type, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $999,999,999 IDC with DLA Troop Support Medical that extends through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations.
This delivery order is scheduled for ultimate completion on January 30, 2026, reflecting the typical expedited timeline for vaccine procurement under the DLA's medical supply chain. PREVNAR 20 is a pneumococcal conjugate vaccine critical for military readiness and the health of service members and veterans. The award demonstrates AmerisourceBergen's continued role as a key pharmaceutical distributor for the Department of Defense medical system, leveraging its comprehensive IDC to provide essential immunization products across multiple therapeutic domains. As a non-set-aside award, this contract was competed on a full and open basis, underscoring the contractor's capability to meet federal procurement requirements for specialized medical commodities.
Quick answers
Who was awarded contract SPE2DR26F5W3G?
SPE2DR26F5W3G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F5W3G worth?
The government has obligated $33,467 on SPE2DR26F5W3G.
Is contract SPE2DR26F5W3G an order under another contract?
Yes. SPE2DR26F5W3G is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5W3G competed?
The extent of competition for SPE2DR26F5W3G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award